Newomics Snags $908,000 in SBIR Grants | GenomeWeb

NEW YORK (GenomeWeb) – Newomics said today that it has received from the National Institutes of Health two Small Business Innovation Research Phase I grants totaling $908,000.

The first grant, which began on May 1, consists of $683,000 over two years to support development of the company's picoelectrospray ionization technology for top-down proteomics applications. The second, which is slated to begin on June 1, provides $225,000 over six months to support development of a platform for high-throughput identification of the molecular targets of natural products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.